EP3283087A4 - METHOD AND SYSTEM FOR DIAGNOSES AND TREATMENTS DERIVED FROM MICROBIOMA FOR ENDOCRINE SYSTEM DYSFUNCTIONS - Google Patents

METHOD AND SYSTEM FOR DIAGNOSES AND TREATMENTS DERIVED FROM MICROBIOMA FOR ENDOCRINE SYSTEM DYSFUNCTIONS Download PDF

Info

Publication number
EP3283087A4
EP3283087A4 EP16780681.9A EP16780681A EP3283087A4 EP 3283087 A4 EP3283087 A4 EP 3283087A4 EP 16780681 A EP16780681 A EP 16780681A EP 3283087 A4 EP3283087 A4 EP 3283087A4
Authority
EP
European Patent Office
Prior art keywords
microbioma
diagnoses
dysfunctions
endocrine
treatments derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16780681.9A
Other languages
German (de)
French (fr)
Other versions
EP3283087A1 (en
Inventor
Zachary APTE
Daniel Almonacid
Jessica RICHMAN
Siavosh Rezvan BEHBAHANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macrogen Inc
Original Assignee
uBiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by uBiome Inc filed Critical uBiome Inc
Publication of EP3283087A1 publication Critical patent/EP3283087A1/en
Publication of EP3283087A4 publication Critical patent/EP3283087A4/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Theoretical Computer Science (AREA)
  • Biophysics (AREA)
  • Databases & Information Systems (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Primary Health Care (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
EP16780681.9A 2015-04-14 2016-04-13 METHOD AND SYSTEM FOR DIAGNOSES AND TREATMENTS DERIVED FROM MICROBIOMA FOR ENDOCRINE SYSTEM DYSFUNCTIONS Pending EP3283087A4 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201562147355P 2015-04-14 2015-04-14
US201562147226P 2015-04-14 2015-04-14
US201562147058P 2015-04-14 2015-04-14
US201562147304P 2015-04-14 2015-04-14
US201562147202P 2015-04-14 2015-04-14
US201562147107P 2015-04-14 2015-04-14
US201562147348P 2015-04-14 2015-04-14
PCT/US2016/027378 WO2016168370A1 (en) 2015-04-14 2016-04-13 Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions

Publications (2)

Publication Number Publication Date
EP3283087A1 EP3283087A1 (en) 2018-02-21
EP3283087A4 true EP3283087A4 (en) 2019-03-13

Family

ID=57126198

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16780681.9A Pending EP3283087A4 (en) 2015-04-14 2016-04-13 METHOD AND SYSTEM FOR DIAGNOSES AND TREATMENTS DERIVED FROM MICROBIOMA FOR ENDOCRINE SYSTEM DYSFUNCTIONS

Country Status (4)

Country Link
EP (1) EP3283087A4 (en)
CN (1) CN107708714B (en)
AU (2) AU2016250159A1 (en)
WO (1) WO2016168370A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3006057A1 (en) * 2015-09-09 2017-03-16 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with thyroid health issues
EP3766073A4 (en) * 2018-03-16 2021-12-15 Psomagen, Inc. METHOD AND SYSTEM FOR CHARACTERIZATION OF METABOLISM ASSOCIATED DISEASES, INCLUDING DIAGNOSTICS AND THERAPIES, BASED ON A BIOINFORMATIC APPROACH
CN114381507B (en) * 2021-11-25 2024-02-13 杭州拓宏生物科技有限公司 Graves disease marker microorganism and application thereof
WO2025131250A1 (en) * 2023-12-19 2025-06-26 N.V. Nutricia A system and method for analysing excreta
CN119296652B (en) * 2024-09-24 2025-10-21 河北大学 Screening method for effector factors in saliva of larvae and oviposition secretions of female nymphs

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
WO2015013214A2 (en) * 2013-07-21 2015-01-29 Whole Biome, Inc. Methods and systems for microbiome characterization, monitoring and treatment

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120149584A1 (en) * 2009-08-21 2012-06-14 Bernat Olle Methods of diagnosing and treating microbiome-associated disease using interaction network parameters
US20130005586A1 (en) * 2010-03-01 2013-01-03 Stanislav Ehrlich Method of diagnostic of obesity
US20130045874A1 (en) * 2010-03-01 2013-02-21 Institut National De La Recherche Agronomique Method of Diagnostic of Inflammatory Bowel Diseases
AU2012332491A1 (en) * 2011-11-04 2014-05-29 General Mills, Inc. Methods and compositions for modulating gastrointestinal bacteria to promote health
JP2016509003A (en) * 2013-02-04 2016-03-24 セレス セラピューティクス インコーポレイテッド Compositions and methods
WO2014190229A1 (en) * 2013-05-24 2014-11-27 President And Fellows Of Harvard College Methods of isolating microorganisms and uses thereof
US20150050245A1 (en) * 2013-08-14 2015-02-19 Tntgamble, Inc. Methods and delivery system for beneficial additive and subtractive biological agents to promote balanced mammalian gastrointestinal flora
WO2016065075A1 (en) * 2014-10-21 2016-04-28 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics
CA2964480A1 (en) * 2014-10-31 2016-05-06 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
CN107708716B (en) * 2015-04-13 2022-12-06 普梭梅根公司 Methods and systems for microbiome-derived diagnosis and treatment of conditions associated with microbiome taxonomic features
WO2016168364A1 (en) * 2015-04-13 2016-10-20 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
EP3283086A4 (en) * 2015-04-13 2019-04-24 Ubiome Inc. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
CN107710205A (en) * 2015-04-14 2018-02-16 优比欧迈公司 For the sign in the microorganism group source of cardiovascular disease condition, diagnosis and the method and system for the treatment of

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
WO2015013214A2 (en) * 2013-07-21 2015-01-29 Whole Biome, Inc. Methods and systems for microbiome characterization, monitoring and treatment

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016168370A1 *
VIRILI CAMILLA ET AL: "Does microbiota composition affect thyroid homeostasis?", ENDOCRINE, HUMANA PRESS, INC, US, vol. 49, no. 3, 17 December 2014 (2014-12-17), pages 583 - 587, XP035520794, ISSN: 1355-008X, [retrieved on 20141217], DOI: 10.1007/S12020-014-0509-2 *

Also Published As

Publication number Publication date
CN107708714A (en) 2018-02-16
AU2022200575A1 (en) 2022-02-17
AU2016250159A1 (en) 2017-11-09
EP3283087A1 (en) 2018-02-21
CN107708714B (en) 2022-07-22
WO2016168370A1 (en) 2016-10-20

Similar Documents

Publication Publication Date Title
EP3347367A4 (en) METHOD AND SYSTEM FOR DIAGNOSIS AND THERAPY DERIVED FROM MICROBIOMA FOR BACTERIAL VAGINOSIS
EP3515284A4 (en) APPARATUS AND METHOD FOR SCREENING
EP3520523A4 (en) METHOD AND APPARATUS FOR DETERMINING A RESOURCE GROUP
EP3457378A4 (en) METHOD AND APPARATUS FOR SPEED PREDICTION
IL254867B (en) Improved method and apparatus for extracting botanical oils
EP3342085C0 (en) METHOD AND APPARATUS FOR LOW LATENCY TRANSMISSIONS
EP3345127A4 (en) METHOD AND SYSTEM FOR MONITORING DRIVING BEHAVIORS
EP3306612A4 (en) METHOD, APPARATUS AND SYSTEM FOR KARAOKE PROCESSING
EP3519745A4 (en) STRUCTURAL PANEL FOR APPARATUS HAVING STAMPED COMPONENTS AND METHOD
EP3379758A4 (en) METHOD AND APPARATUS FOR SERVICE TRANSMISSION
EP3346910A4 (en) METHOD AND SYSTEM FOR DIAGNOSES DERIVED FROM MICROBIOMA AND THERAPEUTIC AGENTS AGAINST ECZEMA
EP3372037C0 (en) METHOD AND APPARATUS FOR MULTI-USER UPLINK
EP3313168A4 (en) SYSTEM AND METHOD FOR PRESCRIPTIVE SEED TREATMENT
EP3484349A4 (en) APPARATUS, METHOD AND SYSTEM FOR NEUROMODULATION
GB201517076D0 (en) Method and apparatus for performing complex fourier transforms
EP3297874A4 (en) VEHICLE INDEPENDENT SECURITY METHOD AND APPARATUS
EP3515031A4 (en) SYSTEM, APPARATUS AND METHOD FOR SESSION PROCESSING
EP3370539C0 (en) ADSORPTION SYSTEM AND METHOD FOR OPERATING AN ADSORPTION SYSTEM
EP3283085A4 (en) METHOD AND SYSTEM FOR MICROBIOMA DERIVATIVES AND DIAGNOSES FOR AFFECTIONS ASSOCIATED WITH MICROBIOMA TAXONOMIC ELEMENTS
EP3324824A4 (en) METHOD, SYSTEM AND APPARATUS FOR TREATING BINOCULAR DYSFUNCTIONS
EP3283087A4 (en) METHOD AND SYSTEM FOR DIAGNOSES AND TREATMENTS DERIVED FROM MICROBIOMA FOR ENDOCRINE SYSTEM DYSFUNCTIONS
EP3349407A4 (en) METHOD FOR REMOVING THE SELF-JAM FROM AN APPARATUS USING A FDR SYSTEM
EP3554122A4 (en) APPARATUS AND METHOD FOR TRANSMISSION
EP3371683A4 (en) SYSTEM AND METHOD FOR DESIGN
BR112015005879A2 (en) imaging apparatus, and method for performing a task of an imaging apparatus.

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171020

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G06F 19/18 20110101AFI20181026BHEP

Ipc: G16H 50/20 20180101ALI20181026BHEP

Ipc: G16H 50/70 20180101ALI20181026BHEP

Ipc: G16H 50/50 20180101ALI20181026BHEP

Ipc: C12Q 1/68 20180101ALI20181026BHEP

Ipc: G06F 19/24 20110101ALI20181026BHEP

Ipc: A61K 35/741 20150101ALI20181026BHEP

Ipc: G01N 33/48 20060101ALI20181026BHEP

Ipc: G01N 33/569 20060101ALI20181026BHEP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0035740000

Ipc: C12Q0001680000

A4 Supplementary search report drawn up and despatched

Effective date: 20190207

RIC1 Information provided on ipc code assigned before grant

Ipc: G16H 50/20 20180101ALI20190218BHEP

Ipc: G01N 33/48 20060101ALI20190218BHEP

Ipc: G01N 33/569 20060101ALI20190218BHEP

Ipc: G16H 50/50 20180101ALI20190218BHEP

Ipc: C12Q 1/68 20180101AFI20190218BHEP

Ipc: A61K 35/741 20150101ALI20190218BHEP

Ipc: G16H 50/70 20180101ALI20190218BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190910

19U Interruption of proceedings before grant

Effective date: 20191011

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20201201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

D18D Application deemed to be withdrawn (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PSOMAGEN, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231024

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MACROGEN INC.